Innovation

Filter news

cooperation
News
2023.07.24
Innovation
Framework Agreement between the Institut Pasteur and Fiocruz for the Development of Innovation and Technology Transfer
The Institut Pasteur and the Oswaldo Cruz Foundation (Fiocruz) have a long-standing partnership, mirroring the strong...
News
2023.07.04
Innovation
Extension of the Scope of the Exclusive Licence Granted by Institut Pasteur to Meletios Therapeutics for the Development of a New Class of Antivirals
The licensing agreement signed in 2022 between Institut Pasteur and Meletios Therapeutics, a French biotechnology...
News
2023.06.14
Innovation
DARRI at the Hellenic Pasteur Institute: Innovation and Technology Transfer Workshop
From June 26 to 29, 2023, The Hellenic Pasteur Institute, member of the Pasteur Network, is organizing a workshop on...
News
2023.06.08
Innovation
Virtual Reality Surgical Planning: AVATAR MEDICAL receives FDA Clearance
On June 8, 2023, AVATAR MEDICAL, a spin-off of the Institut Pasteur and Institut Curie, both granted with the Carnot...
News
2023.06.07
Innovation
New Online Certificate In Healthcare Entrepreneurship
The Institut Pasteur and ESCP Business School in Paris have developed a new online program for learners preparing to...
Quartier Gerland, Lyon
News
2023.05.23
Innovation
Creation of an European Biocluster for Emerging Infectious Diseases
The project "Biocluster Français pour l’Innovation en Infectiologie" (BCF2I) has been selected for the Healthcare...
News
2023.04.28
Vaccins
Lassa fever: promising results for a vaccine candidate in a Phase I clinical trial
The Lassa arenavirus causes hemorrhagic fever and is a major problem in many West African countries, claiming 5,000 to...
Macrophage humain infecté par le virus Lassa (Arénavirus)
News
2023.01.06
Innovation
Development of a pentavalent vaccine against New World arenaviruses
An Institut Pasteur team has successfully developed a pentavalent vaccine against the five pathogenic arenaviruses...
Anticorps SARS-CoV-2
News
2022.12.07
Innovation
SpikImm receives a major funding to accelerate the clinical and industrial development of its monoclonal antibodies against SARS-CoV-2
  SpikImm, a biotech company founded in 2021 by Truffle Capital in collaboration with the Institut Pasteur, has been...

Pages

Back to top